The committee also requested information on why the company charges more for Wegovy when the two medications contain the same compound, semaglutide, and asked whether Novo Nordisk would substantially reduce the prices of both medications
Safety: In September 2025, the FDA issued a statement that compounded semaglutide is risky because these products do not undergo the FDAs review for safety, effectiveness, and quality before being offered to patients
doi:10.3390/antiox13020203
Semaglutide works by targeting GLP-1 receptors in the body, leading to: Enhanced insulin secretion in response to high blood glucose levels Reduction in appetite through central nervous system pathways Slowing gastric emptying , which prolongs satiety after meals In animals, these mechanisms translate into: Improved blood sugar regulation Significant reduction in food intake Promoting weight loss Evidence of Efficacy in Veterinary Medicine While research is still ongoing, preliminary studies and clinical anecdotes suggest that Semaglutide can be an effective tool in managing obesity and related metabolic disorders in pets
In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as effective therapeutic agents, as they stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner, thereby improving glycemic control with a low risk of hypoglycemia [2]
If youre feeling confused about semaglutide vs